Equities researchers at Raymond James assumed coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) in a research report issued on Thursday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the stock. Sanford C. Bernstein cut their target […]